EVLO
NASDAQEvelo Biosciences Inc.
Evelo Biosciences Inc. (EVLO) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. There were no new wire items for EVLO in the last 30 days. The most recent was published Jul 17, 2024.
Latest news
25 items- PRAlltrna Announces Updates to Its Board of DirectorsChris Schade appointed as Board ChairpersonLynne Parshall, Robert Plenge, M.D., Ph.D., and Nancy Simonian, M.D., appointed to Board of DirectorsCAMBRIDGE, Mass., July 17, 2024 /PRNewswire/ -- Alltrna, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the appointment of Chris Schade, Growth Partner at Flagship Pioneering, as Chairperson of the Board, succeeding Noubar Afeyan, Ph.D., Co-Founder of Alltrna and Founder and CEO of Flagship Pioneering. In addition, Alltrna also announced the appointments to the company's Board of Directors of Lynne Parshall, founding Chief Opera
- SECSEC Form EFFECT filed by Evelo Biosciences Inc.EFFECT - Evelo Biosciences, Inc. (0001694665) (Filer)
- SECSEC Form 15-12G filed by Evelo Biosciences Inc.15-12G - Evelo Biosciences, Inc. (0001694665) (Filer)
- SECSEC Form S-8 POS filed by Evelo Biosciences Inc.S-8 POS - Evelo Biosciences, Inc. (0001694665) (Filer)
- SECSEC Form S-8 POS filed by Evelo Biosciences Inc.S-8 POS - Evelo Biosciences, Inc. (0001694665) (Filer)
- SECEvelo Biosciences Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Evelo Biosciences, Inc. (0001694665) (Filer)
- SECSEC Form POS AM filed by Evelo Biosciences Inc.POS AM - Evelo Biosciences, Inc. (0001694665) (Filer)
- SECSEC Form 25-NSE filed by Evelo Biosciences Inc.25-NSE - Evelo Biosciences, Inc. (0001694665) (Subject)
- SECSEC Form DEFA14A filed by Evelo Biosciences Inc.DEFA14A - Evelo Biosciences, Inc. (0001694665) (Filer)
- SECSEC Form DEF 14A filed by Evelo Biosciences Inc.DEF 14A - Evelo Biosciences, Inc. (0001694665) (Filer)
- 13D/GSEC Form SC 13G/A filed by Evelo Biosciences Inc. (Amendment)SC 13G/A - Evelo Biosciences, Inc. (0001694665) (Subject)
- NEWS12 Health Care Stocks Moving In Wednesday's Pre-Market SessionGainers Phio Pharma (NASDAQ:PHIO) stock increased by 33.9% to $1.5 during Wednesday's pre-market session. The company's market cap stands at $3.6 million. Tenax Therapeutics (NASDAQ:TENX) shares moved upwards by 18.41% to $0.4. The market value of their outstanding shares is at $9.4 million. Brainstorm Cell (NASDAQ:BCLI) stock rose 18.0% to $0.36. The market value of their outstanding shares is at $17.6 million. Altamira Therapeutics (NASDAQ:CYTO) stock rose 17.45% to $0.43. The market value of their outstanding shares is at $3.3 million. Rani Therapeutics Hldgs (NASDAQ:RANI) shares moved upwards by 15.41% to $2.62. The company's market cap stands at $67.8 million. Minerva Surgical (NA
- NEWSOn December 1, 2023, Evelo Biosciences Was Notified By NASDAQ's Listing Qualifications That As A Result Of The Events Disclosed In Its Filing On November 21, The Staff Believes That The Company No Longer Has An Operating Business And Is Public Shell-8K
- SECEvelo Biosciences Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Evelo Biosciences, Inc. (0001694665) (Filer)
- SECSEC Form PRE 14A filed by Evelo Biosciences Inc.PRE 14A - Evelo Biosciences, Inc. (0001694665) (Filer)
- NEWS12 Health Care Stocks Moving In Friday's Intraday SessionGainers GeneDx Hldgs (NASDAQ:WGS) stock moved upwards by 39.7% to $1.97 during Friday's regular session. The market value of their outstanding shares is at $50.9 million. Scilex Holding (NASDAQ:SCLX) stock increased by 27.72% to $1.29. The company's market cap stands at $123.6 million. Modular Medical (NASDAQ:MODD) shares rose 21.69% to $1.29. The company's market cap stands at $27.2 million. Sight Sciences (NASDAQ:SGHT) stock rose 18.0% to $2.95. The company's market cap stands at $143.8 million. Gyre Therapeutics (NASDAQ:GYRE) shares increased by 17.62% to $18.95. The company's market cap stands at $1.4 billion. Pasithea Therapeutics (NASDAQ:KTTA) stock moved upwards by 16.66% to $0.
- NEWSUS Stocks Mixed; Dow Gains 50 PointsU.S. stocks traded mixed this morning, with the Dow Jones index gaining around 50 points on Friday. Following the market opening Friday, the Dow traded up 0.14% to 35,323.77 while the NASDAQ fell 0.13% to 14,247.68. The S&P 500 also fell, dropping, 0.02% to 4,555.53. Check This Out: Visa, KeyCorp And 2 Other Stocks Insiders Are Selling Leading and Lagging Sectors Energy shares surged by 0.6% on Friday. In trading on Friday, real estate shares fell by 0.5%. Top Headline Amazon.com Inc.’s (NASDAQ:AMZN) proposed acquisition of iRobot Corp. (NASDAQ:IRBT), the popular Roomba robot vacuum manufacturer, is reportedly on the verge of receiving unconditional approval from European Unio
- NEWSRegarding The Dissolution, Evelo Biosciences' Simba Gill Ceased Serving As The Company's President, CEO And President, And Marella Thorell Ceased Serving As The CFO, Secretary, Treasurer, Principal Financial Officer, And Principal Accounting Officer
- SECEvelo Biosciences Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits8-K - Evelo Biosciences, Inc. (0001694665) (Filer)
- NEWS12 Health Care Stocks Moving In Friday's Intraday SessionGainers Altamira Therapeutics (NASDAQ:CYTO) stock increased by 222.5% to $0.32 during Friday's regular session. As of 12:31 EST, this security is trading at a volume of 248.0 million shares, making up 22940.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.5 million. Fortress Biotech (NASDAQ:FBIO) stock increased by 46.85% to $2.1. Trading volume for this security as of 12:31 EST is 4.8 million, which is 4476.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $31.1 million. As per the news, the Q3 earnings report came out 3 days ago. Kodiak Sciences (NASDAQ:KOD) shares r
- NEWSWhy Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionShares of Shapeways Holdings, Inc. (NASDAQ:SHPW) tumbled during Wednesday’s session following downbeat results. Shapeways Hldgs posted an adjusted loss of $1.36 per share, versus market expectations for a loss of 95 cents per share. The company’s quarterly sales came in at $8.37 million versus estimates of $8.75 million. Shapeways shares fell 20.8% to $2.36 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Taysha Gene Therapies, Inc. (NASDAQ:TSHA) shares climbed 62.4% to $2.16 after the company reported third-quarter results. Chemomab Therapeutics Ltd. (NASDAQ:CMMB) shares jumped 55% to $0.9497 after the FDA granted CM-101 Fast Track designation for
- NEWS12 Health Care Stocks Moving In Wednesday's Intraday SessionGainers Heron Therapeutics (NASDAQ:HRTX) stock moved upwards by 63.0% to $0.88 during Wednesday's regular session. As of 12:31 EST, Heron Therapeutics's stock is trading at a volume of 15.8 million, which is 750.5% of its average full-day volume over the last 100 days. The company's market cap stands at $123.8 million. The company's, Q3 earnings came out yesterday. Kinnate Biopharma (NASDAQ:KNTE) shares increased by 57.32% to $2.47. The current volume of 55.3 million shares is 35889.2% of Kinnate Biopharma's average full-day volume over the last 100 days (last updated at 12:31 EST). The market value of their outstanding shares is at $116.3 million. As per the press release, Q3 earnings cam
- 13D/GSEC Form SC 13G/A filed by Evelo Biosciences Inc. (Amendment)SC 13G/A - Evelo Biosciences, Inc. (0001694665) (Subject)
- SECSEC Form 10-Q filed by Evelo Biosciences Inc.10-Q - Evelo Biosciences, Inc. (0001694665) (Filer)
- INSIDERBodmer Mark converted options into 6,625 shares and sold $1,044 worth of shares (3,163 units at $0.33), increasing direct ownership by 16% to 25,732 units (SEC Form 4)4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
EVLO FAQ
8 questionsWhat does Evelo Biosciences Inc. do?
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in clinical development trial for the treatment of psoriasis and atopic dermatitis, as well as for the hyperinflammatory response associated with COVID-19. The company also engages in developing EDP1867, an inactivated investigational oral biologic for the treatment of inflammatory diseases; EDP2939, an extracellular vesicle investigational oral...What is the latest news on EVLO?
Quantisnow has not tracked any new filings, ratings or press releases for EVLO in the last 30 days. The most recent wire item was published on July 17, 2024.Where does EVLO stock trade?
Evelo Biosciences Inc. (EVLO) is listed on NASDAQ.What sector and industry is EVLO in?
Evelo Biosciences Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Evelo Biosciences Inc. go public?
Evelo Biosciences Inc. (EVLO) completed its IPO in 2018.What are analysts saying about EVLO?
Evelo Biosciences Inc. has had 4 recent analyst actions on file. The most recent action was from JMP Securities: Market Outperform with a $4150.00 price target on 2021-11-02. Recent price targets range from $1200.00 to $4150.00.What companies are similar to EVLO?
Notable peers in the same industry include FHTX (Foghorn Therapeutics Inc.), CDAK (Codiak BioSciences Inc.), KLDO (Kaleido Biosciences Inc.). Compare EVLO side-by-side with any of them on Quantisnow.How can I track EVLO on Quantisnow?
Quantisnow aggregates Evelo Biosciences Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow EVLO to receive live email and push alerts on every new disclosure.